Hohimer Wealth Management LLC Acquires 1,341 Shares of Waters Corporation $WAT

Hohimer Wealth Management LLC acquired a new position in shares of Waters Corporation (NYSE:WAT) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,341 shares of the medical instruments supplier’s stock, valued at approximately $589,000.

Several other institutional investors have also recently made changes to their positions in the company. Candriam S.C.A. raised its holdings in shares of Waters by 21.2% in the third quarter. Candriam S.C.A. now owns 31,187 shares of the medical instruments supplier’s stock valued at $13,753,000 after purchasing an additional 5,462 shares during the last quarter. Ethic Inc. lifted its position in shares of Waters by 7.2% during the third quarter. Ethic Inc. now owns 11,375 shares of the medical instruments supplier’s stock valued at $4,998,000 after purchasing an additional 767 shares in the last quarter. Calamos Wealth Management LLC purchased a new position in Waters during the third quarter worth about $8,715,000. Calamos Advisors LLC boosted its holdings in Waters by 548.9% during the third quarter. Calamos Advisors LLC now owns 51,353 shares of the medical instruments supplier’s stock worth $22,564,000 after purchasing an additional 43,439 shares during the last quarter. Finally, Alta Advisers Ltd bought a new stake in Waters in the 3rd quarter worth about $309,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Up 4.3%

Waters stock opened at $477.12 on Tuesday. The firm has a 50 day moving average price of $435.97 and a 200-day moving average price of $372.64. The company has a quick ratio of 1.29, a current ratio of 0.66 and a debt-to-equity ratio of 0.32. Waters Corporation has a twelve month low of $282.77 and a twelve month high of $482.28. The company has a market capitalization of $46.88 billion, a P/E ratio of 204.77, a P/E/G ratio of 2.71 and a beta of 1.16.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts’ consensus estimates of $4.00 by $0.10. Waters had a net margin of 1.75% and a return on equity of 9.91%. The company had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.75 billion. During the same quarter in the previous year, the firm posted $3.40 EPS. Waters’s revenue was up 120.9% on a year-over-year basis. As a group, equities analysts predict that Waters Corporation will post 14.65 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on WAT shares. Barclays increased their price objective on shares of Waters from $500.00 to $530.00 and gave the company an “overweight” rating in a research note on Wednesday, November 4th. Weiss Ratings upgraded Waters from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. UBS Group raised Waters from a “neutral” rating to a “buy” rating and upped their target price for the company from $375.00 to $490.00 in a report on Wednesday, September 9th. KeyCorp increased their price target on Waters from $460.00 to $500.00 and gave the company an “overweight” rating in a research report on Wednesday, November 4th. Finally, Piper Sandler upgraded Waters from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $400.00 to $480.00 in a report on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $475.48.

About Waters

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.